These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Shigellosis in custodial institutions. II. Clinical, immunologic and bacteriologic response of institutionalized children to oral attenuated shigella vaccines. Levine MM; Dupont HL; Gangarosa EJ; Hornick RB; Snyder MJ; Libonati JP; Glaser K; Formal SB Am J Epidemiol; 1972 Jul; 96(1):40-9. PubMed ID: 4557072 [No Abstract] [Full Text] [Related]
9. Shigellosis in custodial institutions. 3. Prospective clinical and bacteriologic surveillance of children vaccinated with oral attenuated shigella vaccines. Levine MM; Gangarosa EJ; Werner M; Morris GK J Pediatr; 1974 Jun; 84(6):803-6. PubMed ID: 4596999 [No Abstract] [Full Text] [Related]
10. Serum enterotoxin-neutralizing antibody in human shigellosis. Keusch GT; Jacewicz M Nat New Biol; 1973 Jan; 241(105):31-2. PubMed ID: 4572837 [No Abstract] [Full Text] [Related]
11. Live attenuated Shigella flexneri mutants as vaccine candidates against shigellosis and vectors for antigen delivery. Phalipon A; Sansonetti P Biologicals; 1995 Jun; 23(2):125-34. PubMed ID: 7546655 [TBL] [Abstract][Full Text] [Related]
12. Technological aspect of the production of live dysentery vaccines for oral administration. Denchev V; Nenkov P; Vitanov T; Sumerska T; Marinova S; Vassilev T; Panova I; Bratoeva M; Linde K Acta Microbiol Hung; 1991; 38(2):121-6. PubMed ID: 1805499 [TBL] [Abstract][Full Text] [Related]
13. [Passive hemagglutination tests with Shigella flexneri and Shigella sonnei antigens in the diagnosis of dysentery]. Prokopowicz D Wiad Lek; 1972 Jul; 25(11):977-80. PubMed ID: 4557140 [No Abstract] [Full Text] [Related]
14. The cellular and humoral immune response after administration to the guinea pig of Shigella flexneri 2a T32--Istrati vaccinal strain by different routes. Meitert T; Radu I; Ciudin L; Pencu E; Tonciu M Arch Roum Pathol Exp Microbiol; 1978; 37(3-4):267-76. PubMed ID: 395927 [No Abstract] [Full Text] [Related]
15. An outbreak of Sonne shigellosis in a population receiving oral attenuated shigella vaccines. Levine MM; Rice PA; Gangarosa EJ; Morris GK; Snyder MJ; Formal SB; Wells JG; Gemski P; Hammond J Am J Epidemiol; 1974 Jan; 99(1):30-6. PubMed ID: 4590191 [No Abstract] [Full Text] [Related]
17. Attenuated Shigella flexneri 2a Delta guaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosal vaccine against Shigella and ETEC infection. Altboum Z; Barry EM; Losonsky G; Galen JE; Levine MM Infect Immun; 2001 May; 69(5):3150-8. PubMed ID: 11292735 [TBL] [Abstract][Full Text] [Related]
18. Serum antibodies to lipopolysaccharide and natural immunity to shigellosis in an Israeli military population. Cohen D; Green MS; Block C; Rouach T; Ofek I J Infect Dis; 1988 May; 157(5):1068-71. PubMed ID: 3283258 [No Abstract] [Full Text] [Related]
19. [A morphologic study of the harmlessness of live dysentery vaccines from streptomycin dependent mutants of Sh. flexneri]. Levenbuk IS; Sergeev VV; Elkina SI; Kavtaradze KN; Dzhikidze EK Zh Mikrobiol Epidemiol Immunobiol; 1972 Feb; 49(2):18-22. PubMed ID: 4623775 [No Abstract] [Full Text] [Related]